Europlasma and P2i Settle Lawsuit in USA
On March 17, 2015, Europlasma and P2i resolved their dispute in the United States District Court for the Central District of California, Santa Ana Division without any admission or concession of wrongdoing or liability on the part of either Europlasma or P2i.
Europlasma does not and has not infringed the U.S. Reissue Patent No. RE43,651 Patent.
Europlasma ’s non-pulsed plasma technology does not and has not infringed the U.S. Reissue Patent No. RE43,651 Patent.